You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Prediction and Measurement of the Carbon Build-Up in Film-Cooled Rocket Engines

    SBC: SIERRA ENGINEERING, INC.            Topic: AF15AT21

    ABSTRACT: Sierra Engineering Inc. (Sierra) believes that existing chemical kinetic models can be efficiently incorporated into commercial CFD codes to predict the mixing, pyrolysis, soot formation and carbon deposition within film cooled rocket engines. During this Phase I STTR effort we will demonstrate that this analysis capability is practical and that we can generate appropriate model validati ...

    STTR Phase I 2015 Department of DefenseAir Force
  2. STTR Phase I: Advanced Material Recycling for Lithium Ion Battery Electrodes

    SBC: ONTO TECHNOLOGY, LLC            Topic: CT

    The broader impact/commercial potential of this Small Business Innovation Research Phase I project will be to recycle materials for use in manufacture of advanced batteries. Success and commercialization of this projects? technology will facilitate recycling of consumer and electric vehicle waste batteries. The project enhances scientific understanding by demonstrating the durability, robustness a ...

    STTR Phase I 2015 National Science Foundation
  3. STTR Phase I: Next-Generation Microbial Fuel Cell for Highly Efficient Wastewater Treatment

    SBC: WASTE2WATERGY LLC            Topic: CT

    The broader impact/commercial potential of this Small Business Innovation Research Phase I project, if successful, will be to advance the development of a novel microbial fuel cell (MFC) system that generates energy from the wastewaters being treated and that could significantly benefit wastewater treatment for a range of key industries. If successfully developed, the company's new MFC technology ...

    STTR Phase I 2015 National Science Foundation
  4. Correct-by-Construction Synthesis for Multi-Vehicle Autonomy Missions

    SBC: GALOIS, INC.            Topic: AF14AT06

    ABSTRACT: The kinds of capability advancements we anticipate include scalable support for multi-vehicle scenarios with concurrent executions, co-existence of adversarial and cooperative assets, timing and synchronization constraints, heterogeneous sets of specifications (e.g., prioritization over soft vs. hard constraints), and fault-tolerance. The tool development will focus on an open-source so ...

    STTR Phase I 2015 Department of DefenseAir Force
  5. Development of novel compounds for the treatment of atrial fibrillation

    SBC: Elex Biotech, Inc            Topic: NHLBI

    DESCRIPTION provided by applicant Atrial fibrillation AF is the most prevalent type of cardiac arrhythmia in the developed world affecting million people in the United States alone a number that is expected to double by because of population aging Current pharmacological options are ineffective which may be in part because these drugs fail to target key pathogenic mechanisms Recen ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. StrikeVEMP: Automated Portable Bone-Conducted Force Stimuli for Recording Acceleration-Produced coVEMPs

    SBC: Ear And Skull Base Center, Inc.            Topic: NIDCD

    DESCRIPTION provided by applicant Each year million Americans go to health care providers because of vertigo dizziness or balance problems It is the second most common complaint heard in doctorandapos s offices and will occur in of the nationandapos s population at sometime in their lives From through of US adults aged years and older million Americans had ve ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Preclinical and neuroimmunologic study of RTL1000 for methamphetamine addiction

    SBC: VIROGENOMICS BIODEVELOPMENT INC            Topic: R41

    DESCRIPTION provided by applicant Methamphetamine MA dependence is associated with long term damage to regions of the brain that control cognitive and psychiatric function One third to one half of MA dependent adults experience persistent cognitive and other psychiatric disorders up to three years or longer into remission The neuropsychiatric impairments that persist following abstinence ar ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. A screening assay for chemicals that affect the differentiation of human neural cells.

    SBC: NZUMBE INC            Topic: NIEHS

    DESCRIPTION provided by applicant Human brain development represents a highly vulnerable time to chemical exposures because immature cells are actively undergoing differentiation into more complex cell types e g neurons astrocytes oligodendroglia to form neural circuits A major reason for this vulnerability is that neuronal differentiation requires critical time dependent changes to the ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Identifying activators of interferon regulatory factors for neuroprotection

    SBC: Neuralexo, LLC            Topic: NINDS

    DESCRIPTION provided by applicant Stroke is a leading cause of morbidity and mortality in the United States However less than of patients are eligible for the current approved interventions of tissue plasminogen activator or thrombectomy We seek to develop new therapeutics to reduce the extent of damage and functional impairment resulting from ischemic injury to the brain an area of signi ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy

    SBC: STRYKAGEN CORPORATION            Topic: NIAMS

    DESCRIPTION provided by applicant Duchenne muscular dystrophy is caused by mutations in the dystrophin gene resulting in the loss of the dystrophin glycoprotein complex in skeletal muscle Loss of dystrophin results in reduced sarcolemmal integrity progressive muscle damage and compromised muscle function There is currently no cure and limited treatment options for DMD and all affected child ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government